|
| 36711769 | curatedPCaData: Integration of clinical, genomic, and signature features in a curated and harmonized prostate cancer data resource. | bioRxiv | 2023 |
| 37554445 | Down syndrome is associated with altered frequency and functioning of tracheal multiciliated cells, and response to influenza virus infection. | iScience | 2023 |
| 37407670 | A harmonized resource of integrated prostate cancer clinical, -omic, and signature features. | Sci Data | 2023 |
| 37468459 | SIX1 and EWS/FLI1 co-regulate an anti-metastatic gene network in Ewing Sarcoma. | Nat Commun | 2023 |
| 37224225 | Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin. | Sci Transl Med | 2023 |
| 36820825 | Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma. | Cancer Immunol Res | 2023 |
| 35132438 | PRDM paralogs antagonistically balance Wnt/β-catenin activity during craniofacial chondrocyte differentiation. | Development | 2022 |
| 36142576 | High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes. | Int J Mol Sci | 2022 |
| 36139558 | Antigens Expressed by Breast Cancer Cells Undergoing EMT Stimulate Cytotoxic CD8<sup>+</sup> T Cell Immunity. | Cancers (Basel) | 2022 |
| 36216026 | SOPHIE: Generative Neural Networks Separate Common and Specific Transcriptional Responses. | Genomics Proteomics Bioinformatics | 2022 |
| 33947745 | Mediator of DNA Damage Checkpoint 1 (MDC1) Is a Novel Estrogen Receptor Coregulator in Invasive Lobular Carcinoma of the Breast. | Mol Cancer Res | 2021 |
| 33846123 | <i>MAP3K7</i> Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of <i>CHD1</i>. | Mol Cancer Res | 2021 |
| 33526513 | Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer. | Cancer Res | 2021 |
| 34544797 | IL13Rα2 Promotes Proliferation and Outgrowth of Breast Cancer Brain Metastases. | Clin Cancer Res | 2021 |
| 34208794 | Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes. | Cancers (Basel) | 2021 |
| 34195686 | Crowdsourcing assessment of maternal blood multi-omics for predicting gestational age and preterm birth. | Cell Rep Med | 2021 |
| 32460014 | Allele-Specific DNA Methylation and Its Interplay with Repressive Histone Marks at Promoter-Mutant TERT Genes. | Cell Rep | 2020 |
| 31974170 | Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia. | Cancer Discov | 2020 |
| 33196691 | KDM5A and PHF2 positively control expression of pro-metastatic genes repressed by EWS/Fli1, and promote growth and metastatic properties in Ewing sarcoma. | Oncotarget | 2020 |
| 33247183 | Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy. | Commun Biol | 2020 |
| 33218188 | CPT1A Over-Expression Increases Reactive Oxygen Species in the Mitochondria and Promotes Antioxidant Defenses in Prostate Cancer. | Cancers (Basel) | 2020 |
| 33096022 | Biologically Informed Neural Networks Predict Drug Responses. | Cancer Cell | 2020 |
| 32697014 | KDM3A/Ets1 epigenetic axis contributes to PAX3/FOXO1-driven and independent disease-promoting gene expression in fusion-positive Rhabdomyosarcoma. | Mol Oncol | 2020 |
| 32276990 | Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers. | Mol Cancer Res | 2020 |
| 30414698 | A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer. | Eur Urol | 2019 |
| 37736115 | Modeling genetic heterogeneity of drug response and resistance in cancer. | Curr Opin Syst Biol | 2019 |
| 31300540 | Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous Recombination. | Mol Cancer Res | 2019 |
| 31628327 | Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors. | Nat Commun | 2019 |
| 30801016 | Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy. | Sci Adv | 2019 |
| 30606720 | SIX2 Mediates Late-Stage Metastasis via Direct Regulation of <i>SOX2</i> and Induction of a Cancer Stem Cell Program. | Cancer Res | 2019 |
| 29732388 | Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines. | Bladder Cancer | 2018 |
| 29887378 | Next-Generation Machine Learning for Biological Networks. | Cell | 2018 |
| 30127018 | Metastatic cells are preferentially vulnerable to lysosomal inhibition. | Proc Natl Acad Sci U S A | 2018 |
| 29879983 | Simulating heterogeneous populations using Boolean models. | BMC Syst Biol | 2018 |
| 30112438 | A Gene Expression Signature Predicts Bladder Cancer Cell Line Sensitivity to EGFR Inhibition. | Bladder Cancer | 2018 |
| 29950010 | GSEA-InContext: identifying novel and common patterns in expression experiments. | Bioinformatics | 2018 |
| 29757193 | Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulation. | J Clin Invest | 2018 |
| 27270441 | Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response. | Oncogene | 2017 |
| 30657384 | A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer. | JCO Clin Cancer Inform | 2017 |
| 29281820 | Allele-Specific DNA Methylation and Its Interplay with Repressive Histone Marks at Promoter-Mutant TERT Genes. | Cell Rep | 2017 |
| 28958384 | All Paths Lead to TRIM25. | Trends Cancer | 2017 |
| 29137211 | Community mining of open clinical trial data. | Oncotarget | 2017 |
| 27897011 | A SPATIOTEMPORAL MODEL TO SIMULATE CHEMOTHERAPY REGIMENS FOR HETEROGENEOUS BLADDER CANCER METASTASES TO THE LUNG. | Pac Symp Biocomput | 2017 |
| 27864015 | Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data. | Lancet Oncol | 2017 |
| 27312530 | GON4L Drives Cancer Growth through a YY1-Androgen Receptor-CD24 Axis. | Cancer Res | 2016 |
| 26248648 | Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics. | Mol Cancer Res | 2016 |
| 27653685 | Multivalent Chromatin Engagement and Inter-domain Crosstalk Regulate MORC3 ATPase. | Cell Rep | 2016 |
| 27418159 | Crowdsourcing biomedical research: leveraging communities as innovation engines. | Nat Rev Genet | 2016 |
| 25516960 | RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer. | Mol Cancer Res | 2015 |
| 25722414 | Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer. | Science | 2015 |